Elicio Therapeutics's market cap is currently $97.63M. The company's EPS TTM is $-4.11; its P/E ratio is ―; Elicio Therapeutics is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $-0.88. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 28.31M	$ 2.88M	$ 1.49M
Gross Profit	$ -1.17M	$ -1.06M	$ 27.08M	$ 1.06M	$ 351.00K
Operating Income	$ -35.74M	$ -23.73M	$ -25.47M	$ -15.72M	$ -12.34M
EBITDA	$ -32.97M	$ -23.55M	$ -51.92M	$ -15.53M	$ -40.16M
Net Income	$ -35.20M	$ -28.21M	$ -26.40M	$ -15.71M	$ -12.26M
Balance Sheet
Cash & Short-Term Investments	$ 12.89M	$ 6.16M	$ 9.28M	$ 14.97M	$ 6.81M
Total Assets	$ 27.15M	$ 22.66M	$ 14.81M	$ 19.66M	$ 8.84M
Total Debt	$ 6.92M	$ 7.48M	$ 11.80M	$ 439.43K	$ 867.60K
Net Debt	$ -5.98M	$ 1.33M	$ 2.52M	$ -14.53M	$ -5.94M
Total Liabilities	$ 15.77M	$ 124.81M	$ 89.35M	$ 68.80M	$ 43.73M
Stockholders' Equity	$ 11.37M	$ -102.15M	$ -74.54M	$ -49.14M	$ -34.90M
Cash Flow
Free Cash Flow	$ -32.76M	$ -22.83M	$ -24.46M	$ -16.90M	$ -9.78M
Operating Cash Flow	$ -32.69M	$ -22.18M	$ -23.94M	$ -16.70M	$ -9.29M
Investing Cash Flow	$ -32.00K	$ -653.84K	$ -525.36K	$ -199.92K	$ -489.10K
Financing Cash Flow	$ 38.61M	$ 21.20M	$ 19.39M	$ 25.06M	$ 6.29M

Currency in USD

Elicio Therapeutics Earnings and Revenue History

Income Statement >

Elicio Therapeutics Debt to Assets

Balance Sheet >

Elicio Therapeutics Cash Flow

Cash Flow >

Elicio Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing